{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:04:05Z","timestamp":1770537845710,"version":"3.49.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpobgyn.2011.11.006","type":"journal-article","created":{"date-parts":[[2011,12,17]],"date-time":"2011-12-17T19:40:41Z","timestamp":1324150841000},"page":"243-256","source":"Crossref","is-referenced-by-count":33,"title":["Screening for ovarian cancer in the general population"],"prefix":"10.1016","volume":"26","author":[{"given":"Aleksandra","family":"Gentry-Maharaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.11.006_bib1","unstructured":"Cancer Research UK. CancerStats: Ovarian cancer UK incidence statistics; http:\/\/info.cancerresearchuk.org\/cancerstats\/types\/ovary\/incidence\/ [last accessed 05.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib2","unstructured":"Cancer Research UK. CancerStats: ovarian cancer molecular biology and genetics; http:\/\/info.cancerresearchuk.org\/cancerstats\/types\/ovary\/molecularbiologyandgenetics\/ [last accessed 05.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib4","unstructured":"Cancer Research UK. CancerStats: ovarian cancer survival statistics; http:\/\/info.cancerresearchuk.org\/cancerstats\/types\/ovary\/survival\/#stage [last accessed 05.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib5","series-title":"Cancer screening in the European Union, in IARC cancer prevention: cancer screening manuals and guidelines","author":"IARC","year":"2003"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/beog.2002.0297","article-title":"Screening for ovarian cancer","volume":"16","author":"Menon","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","article-title":"CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use","volume":"15","author":"Duffy","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/1940-6207.CAPR-11-0048","article-title":"The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples","volume":"4","author":"Jacobs","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib13","doi-asserted-by":"crossref","first-page":"27371","DOI":"10.1074\/jbc.M103554200","article-title":"Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16","volume":"276","author":"Yin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/clinchem\/44.7.1417","article-title":"Comparison of seven immunoassays for the quantification of CA 125 antigen in serum","volume":"44","author":"Davelaar","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","article-title":"Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125","volume":"2","author":"Kabawat","year":"1983","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib16","first-page":"230","article-title":"Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study","volume":"126","author":"Nouwen","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0305-7372(95)90002-0","article-title":"Tumor markers in the management of patients with ovarian cancer","volume":"21","author":"Tuxen","year":"1995","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9378(96)70381-2","article-title":"Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values","volume":"174","author":"Bon","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910420507","article-title":"Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer","volume":"42","author":"Zurawski","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1994.1093","article-title":"What is a normal CA125 level?","volume":"53","author":"Alagoz","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/clinchem\/43.3.491","article-title":"Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value","volume":"43","author":"Bonfrer","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib24","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2068::AID-CNCR25>3.0.CO;2-8","article-title":"Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women","volume":"85","author":"Jeyarajah","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.2002.6603","article-title":"The significance of serum CA 125 elevation in malignant and nonmalignant diseases","volume":"85","author":"Sjovall","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/ijgc-00009577-200610001-00006","article-title":"Risk of Ovarian Cancer (ROC) Algorithm Increases Specificity of Ca125 in Ovarian Cancer Screening","volume":"16","author":"Gentry-Maharaj","year":"2006","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijgo.2007.06.003","article-title":"Serum CA125 level before the development of ovarian cancer","volume":"99","author":"Kobayashi","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1373\/clinchem.2010.153122","article-title":"CA125 immune complexes in ovarian cancer patients with low CA125 concentrations","volume":"56","author":"Cramer","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib29","first-page":"14","article-title":"Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer","volume":"80","author":"Einhorn","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/bmj.306.6884.1030","article-title":"Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography","volume":"306","author":"Jacobs","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.313.7069.1355","article-title":"Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study","volume":"313","author":"Jacobs","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib32","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6690575","article-title":"Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation","volume":"80","author":"Menon","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1471-0528.2000.tb11685.x","article-title":"Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening","volume":"107","author":"Menon","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib34","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","article-title":"Screening for ovarian cancer: a pilot randomised controlled trial","volume":"353","author":"Jacobs","year":"1999","journal-title":"Lancet"},{"issue":"10 Suppl.","key":"10.1016\/j.bpobgyn.2011.11.006_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1200\/JCO.2003.02.955","article-title":"Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women","volume":"21","author":"Skates","year":"2003","journal-title":"J Clin Oncol"},{"issue":"10 Suppl.","key":"10.1016\/j.bpobgyn.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G","article-title":"Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers","volume":"76","author":"Skates","year":"1995","journal-title":"Cancer"},{"issue":"454","key":"10.1016\/j.bpobgyn.2011.11.006_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1198\/016214501753168145","article-title":"Screening based on risk of cancer calculation from Bayesian hierarchical change point and mixture models of longitudinal markers","volume":"96","author":"Skates","year":"2001","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib39","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1200\/JCO.2005.01.6642","article-title":"Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer","volume":"23","author":"Menon","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib40","doi-asserted-by":"crossref","first-page":"a2079","DOI":"10.1136\/bmj.a2079","article-title":"Recruitment to multicentre trials\u2013lessons from UKCTOCS: descriptive study","volume":"337","author":"Menon","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.15_suppl.5003","article-title":"A prospective US ovarian cancer screening study using the risk of ovarian cancer algorithm (ROCA)","volume":"28","author":"Lu","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bpobgyn.2005.10.017","article-title":"Familial ovarian cancer screening","volume":"20","author":"Rosenthal","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biostatistics\/4.1.27","article-title":"A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker","volume":"4","author":"McIntosh","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.21616","article-title":"Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma","volume":"106","author":"Engelen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygyno.2005.07.008","article-title":"Who should operate on patients with ovarian cancer? An evidence-based review","volume":"99","author":"Giede","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2011.11.006_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1525-1438.2006.00319.x","article-title":"Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals","volume":"16","author":"Paulsen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1525-1438.2006.00753.x","article-title":"Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy","volume":"17","author":"van Trappen","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib48","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2011.11.006_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2011.11.006_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens","volume":"4","author":"Cramer","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2007.08.009","article-title":"Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer","volume":"107","author":"Zhang","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib54","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2011.05.039","article-title":"Comparison of candidate serologic markers for type I and type II ovarian cancer","volume":"122","author":"Lu","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib55","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-07-1569","article-title":"Diagnostic markers for early detection of ovarian cancer","volume":"14","author":"Visintin","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2011.11.006_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study","volume":"102","author":"Anderson","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.bpobgyn.2011.11.006_bib57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-10-0193","article-title":"A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer","volume":"4","author":"Zhu","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1998.4965","article-title":"The malignant potential of small cystic ovarian tumors in women over 50 years of age","volume":"69","author":"Bailey","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/uog.212","article-title":"Frequency and type of adnexal lesions in autopsy material from postmenopausal women: ultrasound study with histological correlation","volume":"22","author":"Valentin","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1469-0705.1997.10030192.x","article-title":"Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study","volume":"10","author":"Ferrazzi","year":"1997","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1 Pt 1","key":"10.1016\/j.bpobgyn.2011.11.006_bib61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9378(94)70388-4","article-title":"Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system","volume":"170","author":"Lerner","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib62","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/gyno.2000.6052","article-title":"Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models","volume":"80","author":"Mol","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib63","first-page":"70","article-title":"Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy","volume":"78","author":"Sassone","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9378(99)70436-9","article-title":"A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model","volume":"181","author":"Timmerman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0090-8258(03)00414-1","article-title":"Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography","volume":"91","author":"Ueland","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-8258(89)90031-0","article-title":"Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation","volume":"35","author":"Granberg","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0029-7844(03)00670-7","article-title":"Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter","volume":"102","author":"Modesitt","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib68","article-title":"Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study","author":"Sharma","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1469-0705.2002.00709.x","article-title":"The natural history of adnexal cysts incidentally detected at transvaginal ultrasound examination in postmenopausal women","volume":"20","author":"Valentin","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2011.11.006_bib70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7863\/jum.2011.30.7.943","article-title":"Stage IA ovarian cancers: comparison of sonographic findings and histopathologic types between patients with normal and elevated serum cancer antigen 125 levels","volume":"30","author":"Hirai","year":"2011","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib71","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"2 Pt 1","key":"10.1016\/j.bpobgyn.2011.11.006_bib72","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/AOG.0b013e318195ad17","article-title":"The accuracy of risk scores in predicting ovarian malignancy: a systematic review","volume":"113","author":"Geomini","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/gyno.2001.6253","article-title":"Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction","volume":"82","author":"Cohen","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1469-0705.2000.00185.x","article-title":"Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions","volume":"16","author":"Kurjak","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2007.03.011","article-title":"Is three-dimensional ultrasonography of additional value in the assessment of adnexal masses?","volume":"106","author":"Geomini","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib76","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1471-0528.1999.tb08117.x","article-title":"Neural networks in the diagnosis of malignant ovarian tumours","volume":"106","author":"Clayton","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-0528.1999.tb08080.x","article-title":"Sonographic prediction of malignancy in adnexal masses using an artificial neural network","volume":"106","author":"Tailor","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1469-0705.1999.13010017.x","article-title":"Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses","volume":"13","author":"Timmerman","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.0960-7692.2001.00500.x","article-title":"Comparison of \u2018pattern recognition\u2019 and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation","volume":"18","author":"Valentin","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib80","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1469-0705.2000.00276.x","article-title":"Lack of standardization in gynecological ultrasonography","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib81","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/djm199","article-title":"Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125","volume":"99","author":"Van Calster","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib82","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1469-0705.1999.14050338.x","article-title":"Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound","volume":"14","author":"Valentin","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib83","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/cncr.22594","article-title":"Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened","volume":"109","author":"van Nagell","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib84","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1525-1438.2007.01035.x","article-title":"A randomized study of screening for ovarian cancer: a multicenter study in Japan","volume":"18","author":"Kobayashi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib85","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib86","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib87","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.bpobgyn.2011.11.006_bib88","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/jama.2011.1461","article-title":"Ovarian cancer screening and mortality","volume":"306","author":"Menon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib89","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.424","article-title":"A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2","volume":"41","author":"Song","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib90","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ng.668","article-title":"A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24","volume":"42","author":"Goode","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib91","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib93","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1200\/JCO.2005.03.909","article-title":"Screening for familial ovarian cancer: the need for well-designed prospective studies","volume":"23","author":"Jacobs","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib94","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jmg.2009.067462","article-title":"Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers","volume":"46","author":"Manchanda","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib95","series-title":"The UK Familial Ovarian Cancer Screening Study (UK FOCSS): phase 1: results Of annual screening","author":"Rosenthal","year":"2009"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib96","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib97","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-0528.2005.00572.x","article-title":"Symptoms associated with diagnosis of ovarian cancer: a systematic review","volume":"112","author":"Bankhead","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib98","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cncr.22371","article-title":"Development of an ovarian cancer symptom index: possibilities for earlier detection","volume":"109","author":"Goff","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib99","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","article-title":"Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer","volume":"116","author":"Andersen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.006_bib100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1471-0528.2006.01153.x","article-title":"Feasibility of screening for ovarian cancer using symptoms as selection criteria","volume":"114","author":"Rufford","year":"2007","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.bpobgyn.2011.11.006_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.12.042","article-title":"Validation of serum biomarkers for detection of early-stage ovarian cancer","volume":"200","author":"Nosov","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T01:09:13Z","timestamp":1742087353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693411001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521693411001684"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.11.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}